Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Optimizing Dosing Strategies in Oral Iron Supplementation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dosing strategies for oral iron supplementation to treat iron deficiency and iron deficiency anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral iron supplementation

Snippet

Sponsor: Luzerner Kantonsspital | Conditions: Iron Deficiencies, Iron Deficiency Anemia | Phase 4 | Status: COMPLETED